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Treatment of sonicated calf thymus DNA with the antitumor active metallocene Cp,MoCl, afforded a metallocene-DNA complex which was 
characterized by “P NMR spectroscopy. In addition to the resonance for the phosphate backbone (6 -1.6), the spectrum contained 2 signals 
assigned to a phosphate bound No-DNA complex(es) (6 37.2,36.5) and a broad signal at S 6.2 ppm. This result suggests that covalent attachment 
of the metaIio~ne Cp,MoCI, occurs via phosphat~0) coordination and is accompanied by local disto~ion of the DNA backbone. This result 
supports recent ICP studies with CpzTiCI, that have DNA detected DNA-met~I~ne adducts. 
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1. I~RODUCTION 
The metallocene dichlorides, CpzTiCl,, Cp,VCl,, 
CpzNbCl, and Cp,MoCl, exhibit antitumor activity for 
a wide range of murine and human tumors [I]. Admin- 
istration of Cp,TiCl, or Cp,VCl, inhibits cellular DNA 
synthesis [2], and it has been suggested [1,2] that the 
cytotoxicity of metallocenes is related to the formation 
of cisplatin-like adducts [3] with DNA. However, exten- 
sive studies on the aqueous chemistry and the binding 
sites of metallocenes with nucleobases and nucleotides 
show conclusively that cisplatin type adducts do not 
form [4]. Rapid hydrolysis of both the halide ligands 
and the cyclopentadienyl (Cp) rings in Cp,MX, occurs 
in aqueous solution, the rate of both processes being 
dependent on the metal atom [4]. Nevertheless, induc- 
tively coupled plasma spectroscopy (ICP) measure- 
ments on the interaction of tritinm labelled metallo- 
cenes with calf thymus DNA have detected the presence 
of a Cp,Ti-DNA adduct at pH 5.2 and a CpTi-DNA 
adduct at pH 5.8 IS], confining studies that implicate 
DNA as a site of interaction of metallocenes in cells. 
tent with formation of phosphate centred complexes 
which do not disrupt the W-C base-pairs. It has not 
been established whether similar complexes are formed 
with bulk DNA. In duplex DNA there are steric con- 
straints imposed by the stacked base pairs (Fig. 2) that 
need to be considered and that may lead to formation 
of different complexes than those formed with isolated 
base-pairs. 
This paper reports a NMR spectroscopic study of the 
interactions of the metallocene Cp,MoCl, with calf thy- 
mus DNA fragments. 31P NMR spectroscopy was used 
to confirm the presence of isolable metallocene-DNA 
adducts, previously detected by ICP spectroscopy, and 
to provide information regarding the type of complexes 
formed. 
2. EXPERIMENTAL 
2.1. Calf thymus DNA 
Studies of the interactions of CpzMX, (M = Ti, V, 
MO) with nucleotides uggest hat the most likely coor- 
dination sites on DNA are the phosphate oxygens and/ 
or the heterocyclic nitrogens in the nucleic bases [4]. The 
improved hydrolytic stability of the MO-Cp bonds in 
Cp,MoCl, compared to Cp,TiCl, have allowed several 
adducts formed between Cp,MoCl, and nucleotides to 
be identified [4] (Fig. 1). NMR studies of the interaction 
of Cp,MoCl, with A-T and G-C base-pairs are consis- 
Calf thymus DNA (Sigma, sodium salt, Type I, 160 mglml), was 
son&ted (50% duty cycle) at the maximum output power below 
cavitation by the use of a tapered probe of a Branson Model 250 
sonicator. Solutions were 8-12 ml containing NaCl (0.2 M) and held 
at @-2°C. After 6 h sonication, the samples were ~ntrifug~ at 14,000 
for 1 h. The su~matant was dialyzed twice against a 1 1 solution 
containing NaCl (0.2 M), cacodylate (10 mM) and Na,EDTA at pH 
7.0 for 24 h using a 12-14 kDa membrane. Further dialysis against 1 
I of NaCI (0.1 M) was carried out for 24 h prior to lyophilisation. 
2.2. ~NA-metaliocene adducts 
Correspondence address: M.M. Harding, Department of Organic 
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In a typical experiment, he DNA-metallocene complexes were pre- 
pared in sodium perchlorate (110 mM) by addition of sonicated DNA 
solution (2 ml, 5 mM determined by UV absorbance at 260 nm, E 
6,600) under nitrogen to a septum-capped vial containing the metailo- 
cene (5 mg). The mixture was stirred at 3’7°C for 30 min prior to 
filtration through a glass woo1 plug. The complex was dialysed against 
11 of NaCl(O.1 M) for 12 h through a 12-14 kDa membrane to remove 
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unreacted and hydrolyzed metallocene products, and was then lyophil- 
ized. NMR samples were prepared by addition of H,O/D*O directly 
to these samples to give sample concentrations 0.1-1.0 M NaCl and 
at pH 7.0. 
2.3. Molecular modelling 
Modelling was carried out using MacroModel (version 3.1X) [6] on 
a Silicon Graphics 4D/30 personal workstation. A sequence of DNA 
was generated in the B-conformation and a metallocene Cp,M+ (built 
from X-ray coordinates), was manually docked at potential coordina- 
tion sites along the helix, using the bumpcheck option to monitor the 
presence of non-bonded interactions. 
3. RESULTS 
Short fragments of calf thymus DNA (150-200 base 
pairs) were prepared by sonication [7] and were used in 
order to obtain NMR spectra that were sufficiently well 
resolved to allow partial assignment of the DNA and 
metallocene signals. The metallocene Cp,MoC& was 
studied due to the relative stability of the Cp rings to- 
ward protonolysis in aqueous solution and the data 
available on the nucleotide adducts formed with 
Cp,MoCl, [4]. 
Fig. 3a shows the 31P NMR spectrum of sonicated 
calf thymus DNA and this shows a single resonance for 
all the phosphate groups (S -1.6) ppm. The spectrum 
of the same sample that has been treated with 
Cp,MoC& (Fig. 3b) contains, in addition to the reso- 
nance due to the backbone phosphates, three new sig- 
nals - a broad signal at S 6.2 ppm and two downfield 
singlets (S 37.2, 36.5 ppm). The relative intensities of 
these 3 new signals, by integration, were estimated to be 
2: 1: 1 respectively. The downfield singlets were assigned 
to a molybdenum phosphate (Moo-P) complex(es), as 
these resonances appear in the same region as the 31P 
resonances in Cp,Mo(S’-dAMP) (6 35.8 ppm, Fig. la) 
[4]. For comparison, the signal due to uncomplexed 
5’-dAMP appears at 6 -0.04 ppm. The new broad signal 
(6 6.2) adjacent to the backbone signal, was assigned 
to the phosphates near to the site of metal coordination. 
The appearance of a new signal slightly downfield (C 4 
ppm) from the DNA backbone 31P resonance has been 
observed in previous studies of drug-DNA complexes 
“p, ,,$” 
MO 
0’ \ NH, -n I I 0 w’ “\” 0 
[8], and reflects the local distortion of the backbone that 
occurs due to formation of the complex. In the present 
study, the new signal at 6 6.1 ppm is further downfield 
than the corresponding signal reported for intercalator 
and groove-binding DNA complexes. This larger 
change in chemical shift may partly be attributed to 
deshielding effects present due to the Cp rings in the 
adduct, but overall, suggests that the structure of the 
metallocene-DNA complex is significantly different 
from those drug-DNA complexes previously character- 
ized by 3’P NMR spectroscopy. 
4. DISCUSSION 
While the antitumor properties of the metallocene 
dihalides are well established, the mechanism of action 
of this class of compounds is poorly understood [1,2,9]. 
Interaction of metallocenes with DNA is assumed to 
play a significant role in this process since the metallo- 
cenes inhibit nucleic acid synthesis and the metals de- 
rived from these compounds accumulate in nucleic acid 
rich regions of tumor cells 191. 
Both the shape and size of the metallocenes are mark- 
edly different from other known organometallic agents 
that interact with DNA, notably cisplatin. ICP experi- 
ments [5], which indicate that the cyclopentadiene rings 
remain coordinated to the metal in metallocene-DNA 
complexes formed with Cp,TiC&, suggest hat the hal- 
ide ligands are replaced by other coordinating ligands 
present in DNA. In B-DNA, the most likely competitive 
ligands are nitrogen (present in the nucleobases) and 
oxygen (present in the phosphate groups) and metallo- 
cene complexes involving both these groups have been 
detected by Kuo et al. (Fig. 1) [4]. 
Molecular modelling studies, in which a metallocene 
Cp,MX, was manually docked into both the major and 
minor grooves of DNA and the halide ligands were 
replaced with N donor or phosphate(O) ligands, were 
carried out. Due to the tetrahedral coordination of the 
central metal, formation of a complex using a nitrogen 
from one of the base pairs (as in Fig. 1) pointing into 









(d) X = Ha0 or N3 
Fig. 1. Complexes formed in aqueous olution between Cp,MoCI, and (a) 5’-dAMP, (b) methyl ester of 5’-dGMP, (c) S-dTMP, (d) 5’-dCMP 
(from [4]). 
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phosphate oxygens 
distance 6.8-7.2 a 
A-T base-pair G-C base-pair 
MAJOR GROOVE MAJOR GROOVE H 
MINOR GROOVE MINOR GROOVE 
Fig. 2. Section of B-DNA and Watson-Crick base pairs. Arrows indicate potential nitrogen and oxygen coordination sites. 
steric interactions between the coordinated Cp rings 
with the base-pairs above and below the coordination 
site. While DNA is conformationally flexible and can 
distort its structure on binding, modelling suggests that 
very severe distortion of regular DNA structure would 
be required to allow fo~ation of such a complex. A 
similar conclusion has been reached by Kuo et al. [4] in 
attempts to model possible cisplatin type adducts. In 
contrast, phosphate coordination on the DNA back- 
bone can occur with no (or little) steric impediment. It 
is possible for two phosphate(O) ligands on adjacent 
nucleotides to coordinate to the molybdenum centre. 
The distance between the oxygen donor atoms is - 7 A 
(Fig. 2) while the ‘bite’ of metallocenes is - 334 A [l] 
and hence formation of such a complex would be ex- 
pected to be accompanied by local distortion of the 
DNA backbone. Alternatively, the MO coordinate 
sphere could be satisfied by one phosphate(O) and a 
solvent molecule or by a solvent mediated bridge to a 
second ligand (see Fig. 1 b,d). 
Numerous NMR studies of the interactions of drugs 
and small molecules with short oligonucleotides have 
been reported [IO]. In the present study, long DNA 
sequences were used in preference to short oligonucleo- 
tides in order to eliminate possible formation of com- 
plexes involving the sterically accessible terminal base 
Fig. 3. “P NMR spectra of (a) calf thymus DNA, (b) calf thymus 
DNA incubated with Cp,MoCl,. Spectra were recorded on a Bruker 
AMX400 spectrometer (“P(‘H) 161.98 MHz) at 3OOK, with quadra- 
ture detection employed throughout. Chemical shifts are in parts per 
miltion (ppm) referenced to external neat t~methyl phosphite (140.85 
ppm). Spectra were recorded over 16K data points, SW 2OOpm, spec- 
trum (a) 10,000 scans, (b) 20,000 scans. An exponential Iine-broaden- 
ing factor of 30 was applied to both FID’s prior to Fourier transfor- 
mation. 
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pairs and terminal phosphate groups. In addition, as 
discussed above, modelling suggested that should phos- 
phate coordination occur, this could be a~ompanied by 
substantial distortion of the backbone, which would be 
favoured by the extra stability present in longer se- 
quences of DNA. Several NMR studies of the interac- 
tion of drugs with calf thymus DNA have been reported 
[7,11,12]. From the systems studied to date, 31P NMR 
provides a convenient monitor of the phosphate ester 
backbone confo~ational changes upon binding of in- 
tercalating drugs, and chemical shift changes and have 
been used to assess differences in duplex unwinding 
angles of DNA in the presence of several intercalating 
drugs [7,8]. 
The interaction of Cp,MoCl, with DNA appears to 
be totally different from other ‘classic’ DNA binders 
(intercalators, groove binders, charged compounds) 
and cisplatin and related compounds. The new reso- 
nances observed in the 3’P spectrum obtained after in- 
teraction of Cp,MoCl, with DNA (Fig. 3b) are consis- 
tent with coordination of Cp,MoCl, to phosphate 
groups on the DNA backbone. In aqueous solutions of 
Cp,MoCl,, the major species present is believed to be 
Cp~Mo(H~O)(H~O)+ [4]. This cation may lose one or 
both ancillary ligands to become covalently attached to 
the DNA backbone via either one or two phosphate(O) 
bonds giving rise to one or two new phosphorus reso- 
nances as observed at 6 37.2, 36.5. While the exact 
structure of these complexes remains to be determined, 
the simultaneous appearance of a new resonance at 6 
6.2 suggests that formation of the complex(es) is accom- 
panied by local distortion of the DNA backbone. This 
distortion could arise if there is simultaneous coordina- 
tion of Cp,Mo’ to two phosphate(O) atoms on adjacent 
nucleotides. Fo~ation of such a complex would re- 
quire the distance between the phosphate(O) groups to 
be reduced, unlike the process that occurs on intercala- 
tion where gradual unwinding of the helix occurs. Nar- 
rowing of the O-P-O bond angle is expected to produce 
a downfield shift of the 3LP resonance [13] and such 
bridging of neighbouring nucleotides may explain the 
unusual chemical shift of the signal at 6 6.2 ppm. 
Clearly further data obtained with short oligonucleo- 
tides is required to conclusively establish the nature of 
these adducts. 
To our knowledge this is the first example of forma- 
tion of a drug-DNA complex which appears to be cen- 
tred on the phosphate backbone. Whether this property 
is related to the antitumor activity of Cp,MoCl, remains 
to be investigated. Experiments are underway with 
short DNA duplexes in order to fully characterize met- 
allocene-DNA interactions and establish their role in 
the antineoplastic properties of this class of compounds. 
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